Those are good points, thanks. Probably makes sense for people who got mRNA to switch to non-mRNA for ongoing boosters, to be cautious. But the advantages you

Those are good points, thanks. Probably makes sense for people who got mRNA to switch to non-mRNA for ongoing boosters, to be cautious. But the advantages you cite will surely cause pressure to use it more, especially for moving targets like the flu. I hope we have more details soon about the bounds of "multiple doses" and the potential issues associated.